Nanopublications LDF server

Matches in Nanopublications for { <arcp://name,uts_public_data_repo/2cd6cc6014fd11eeacf4b15b8fae1d4e> ?p ?o ?g. }

• 2cd6cc6014fd11eeacf4b15b8fae1d4e type Dataset assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e type Object assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e name "Inah Camaya PhD Thesis - Supplementary Data" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e contactPoint _1 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e conformsTo Object assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e description "Supplementary data related to the analysis of differential abundance of proteins and the differential expression of miRNA:mRNA in beta cells treated with FhHDM-1 under basal and apoptotic/inflammatory conditions Supplementary Table 3.1. Proteins with significantly different abundance in FhHDM-1 treated β-cells compared to untreated controls Supplementary Table 4.1. Predicted gene targets for differentially expressed miRNAs in FhHDM-1 treated β-cells compared to untreated (Un) controls Supplementary Table 4.2. Predicted gene targets of differentially expressed miRNAs in FhHDM-1 treated β-cells compared to untreated (Un) controls, common across all online miRNA gene target prediction tools mIRDB, DIANA and Target Scan Supplementary Table 4.3A. List of predicted gene targets from miRNA upregulated in FhHDM-1 treated β-cells within each PANTHER DB category of molecular function and biological process (from Figure 2). Supplementary Table 4.3B. KEGG pathway analysis of predicted gene targets from miRNA downregulated in FhHDM-1 treated β-cells compared to untreated controls Supplementary Table 4.4. List of matched gene targets from miRNA downregulated in FhHDM-1 treated β-cells within each PANTHER DB category of molecular function and biological process (from Figure 4.5). Supplementary Table 4.5. Differentially expressed miRNAs in FhHDM-1 treated β-cells exposed to pro-inflammatory cytokines, compared to cytokines alone Supplementary Table 4.6. Predicted gene targets for differentially expressed miRNAs in FhHDM-1 treated β-cells exposed to pro-inflammatory cytokines compared to cytokines (CM) alone Supplementary Table 4.7. Predicted gene targets of differentially expressed miRNAs in FhHDM-1 treated β-cells exposed to pro-inflammatory cytokines compared to cytokines (CM) alone, common across all online miRNA gene target prediction tools mIRDB, DIANA and Target Scan Supplementary Table 4.8. KEGG pathway analysis of predicted gene targets from miRNA upregulated in FhHDM-1 treated β-cells exposed to pro-inflammatory cytokines compared to cytokines alone Supplementary Table 4.9. KEGG pathway analysis of predicted gene targets from miRNA downregulated in FhHDM-1 treated β-cells exposed to pro-inflammatory cytokines compared to cyokines alone Supplementary Table 4.10. Differentially expressed genes in the transcriptome of FhHDM-1 treated β-cells exposed to pro-inflammatory cytokines, compared to cytokines alone Supplementary Table 4.11. Matched gene targets common between transcriptome and predicted gene targets of differentially expressed miRNA in FhHDM-1 treated β-cells under inflammatory conditions compared to pro-inflammatory cytokine only (CM) controls. Supplementary Table 4.12. KEGG pathway analysis of matched genes downregulated in the transcriptome with their corresponding regulatory miRNA upregulated in FhHDM-1 β-cells exposed to pro-inflammatory cytokines compared to cytokines alone Supplementary Table 4.13. KEGG pathway analysis of matched genes upregulated in the transcriptome with their corresponding regulatory miRNA downregulated in FhHDM-1 β-cells exposed to pro-inflammatory cytokines compared to cytokines alone " assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e citation 1753-0407.13252 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e citation s00109-021-02122-x assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e citation yy89-dk26 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e contentUrl "./" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e creator Sheila.Donnelly@uts.edu.au assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e creator Bronwyn.Obrien@uts.edu.au assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e creator Inah.Camaya@uts.edu.au assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e datePublished "2023-07-05T23:09:32.895Z" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e identifier _2 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e identifier _3 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e identifier "2cd6cc6014fd11eeacf4b15b8fae1d4e" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e license _4 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e publisher www.uts.edu.au assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e dateCreated "2023-07-05T23:09:32.895Z" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e memberOf uts_root_collection assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "Fasciola" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "FhHDM" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "IGF" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "PI3K" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "apoptosis" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "beta cell" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "helminth" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "miRNA" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e keywords "type 1 diabetes" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e temporalCoverage "2023-06-30/2029-12-31; N/A" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e yearCreated "2023" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e yearPublished "2023" assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e spatialCoverage _5 assertion.
• 2cd6cc6014fd11eeacf4b15b8fae1d4e conditionsOfAccess "Please contact the data manager for this publication for access" assertion.